Cook Anthony, Khoury Antoine, Kader Karim, Hebert Diane, Navarro Oscar, Pippi-Salle Joao, Farhat Walid
Division of Pediatric Urology, Alberta Children's Hospital, Calgary, Alberta, Canada.
Pediatr Transplant. 2006 Aug;10(5):608-12. doi: 10.1111/j.1399-3046.2006.00523.x.
PSV of renal transplant vessels, calculated during allograft ultrasonography, has previously been shown to correlate with TRAS. Controversy exists regarding the threshold PSV value (adult range: 1.5-3.0 ms), which should prompt further, more invasive investigations to confirm the diagnosis of TRAS. Furthermore, there is a paucity of literature regarding PSV values in the pediatric renal transplant population. In a group of pediatric renal transplant patients, we correlated post-operative renal transplant PSV values with BP, renal function (serum creatinine) and TRAS. All patients who underwent cadaveric or living-related renal transplantation at the HSC between 2001 and 2004 with at least 6 months of follow-up were reviewed through the HSC multi-organ transplant database. Post-operative allograft Doppler ultrasonography was performed during routine follow-up. PSV values obtained were correlated with BP and serum creatinine performed concomitantly. Finally, we correlated PSV in those patients who underwent more intensive investigations, including magnetic resonance and conventional angiography. Fifty-three patients underwent transplantation during the study period. Complete data available for 50/53 demonstrated a mean PSV of 2.13 m/s (range: 0.9-6.1 m/s) for all patients. Of six patients who underwent MRA for suspicion of TRAS, two (with mean PSV values of 1.93 m/s) were found to have clinically significant stenoses. Four of six without angiographic evidence of TRAS had mean PSV values of 2.22 m/s. Patients suspected of having TRAS demonstrated elevated median serum creatinine values compared with those without clinical suspicion of TRAS. However, both mean PSV and BP were not found to be statistically different in both patient subgroups. Furthermore, there was no correlation identified between PSV and serum creatinine and BP in these patient populations. Despite the utility of PSV for monitoring adult renal transplant patients, we did not find that PSV correlated with BP, nadir creatinine or identify those patients who, through subsequent investigations, were found to have TRAS in this pediatric population. Maintaining cognizance in conjunction with close clinical follow-up may identify patients at risk for this rare but potentially morbid complication of transplantation.
在同种异体移植超声检查期间计算的肾移植血管的峰值收缩速度(PSV),此前已被证明与移植肾动脉狭窄(TRAS)相关。关于应促使进一步进行更具侵入性检查以确诊TRAS的PSV阈值(成人范围:1.5 - 3.0米/秒)存在争议。此外,关于小儿肾移植人群中PSV值的文献较少。在一组小儿肾移植患者中,我们将术后肾移植PSV值与血压、肾功能(血清肌酐)和TRAS进行了关联。通过HSC多器官移植数据库对2001年至2004年期间在HSC接受尸体或亲属活体肾移植且至少随访6个月的所有患者进行了回顾。在常规随访期间进行术后同种异体移植多普勒超声检查。获得的PSV值与同时进行的血压和血清肌酐进行关联。最后,我们对那些接受了包括磁共振和传统血管造影在内的更深入检查的患者的PSV进行了关联。在研究期间有53名患者接受了移植。53例中有50例可获得完整数据,所有患者的平均PSV为2.13米/秒(范围:0.9 - 6.1米/秒)。在因怀疑TRAS而接受磁共振血管造影(MRA)的6例患者中,2例(平均PSV值为1.93米/秒)被发现有具有临床意义的狭窄。6例中没有血管造影证据显示TRAS的患者中有4例平均PSV值为2.22米/秒。与没有临床怀疑TRAS的患者相比,怀疑患有TRAS的患者血清肌酐中位数升高。然而,在这两个患者亚组中,平均PSV和血压在统计学上均无差异。此外,在这些患者群体中未发现PSV与血清肌酐及血压之间存在相关性。尽管PSV对监测成人肾移植患者有用,但我们发现在这个小儿人群中,PSV与血压、最低肌酐值无关,也无法识别那些通过后续检查被发现患有TRAS的患者。结合密切的临床随访保持警觉,可能会识别出有这种罕见但潜在致病的移植并发症风险的患者。